Abstract
We described a case of fatal bacteremia related to Capnocytophaga sputigena in a hematological patient. The strain was identified by 16S rRNA gene sequencing.
Publication types
-
Case Reports
-
English Abstract
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bacteremia / complications
-
Bacteremia / diagnosis
-
Bacteremia / microbiology*
-
Capnocytophaga / genetics
-
Capnocytophaga / isolation & purification*
-
Carboplatin / administration & dosage
-
Carboplatin / adverse effects
-
Coinfection
-
Combined Modality Therapy
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / adverse effects
-
DNA, Bacterial / analysis*
-
DNA, Bacterial / genetics
-
DNA, Ribosomal / analysis*
-
DNA, Ribosomal / genetics
-
Doxorubicin / administration & dosage
-
Doxorubicin / adverse effects
-
Etoposide / administration & dosage
-
Etoposide / adverse effects
-
Fatal Outcome
-
Gram-Negative Bacterial Infections / complications
-
Gram-Negative Bacterial Infections / diagnosis
-
Gram-Negative Bacterial Infections / microbiology*
-
Humans
-
Ifosfamide / administration & dosage
-
Ifosfamide / adverse effects
-
Immunocompromised Host
-
Lymphoma, T-Cell / complications*
-
Lymphoma, T-Cell / drug therapy
-
Lymphoma, T-Cell / radiotherapy
-
Male
-
Multiple Organ Failure / etiology
-
Opportunistic Infections / complications
-
Opportunistic Infections / diagnosis
-
Opportunistic Infections / microbiology*
-
Prednisone / administration & dosage
-
Prednisone / adverse effects
-
RNA, Bacterial / genetics*
-
RNA, Ribosomal, 16S / genetics*
-
Ribotyping*
-
Vincristine / administration & dosage
-
Vincristine / adverse effects
Substances
-
DNA, Bacterial
-
DNA, Ribosomal
-
RNA, Bacterial
-
RNA, Ribosomal, 16S
-
Vincristine
-
Etoposide
-
Doxorubicin
-
Cyclophosphamide
-
Carboplatin
-
Ifosfamide
-
Prednisone
Supplementary concepts
-
CHOP protocol
-
ICE protocol 3